- Report
- March 2025
- 200 Pages
Global
From €3975EUR$4,490USD£3,443GBP
- Report
- May 2025
- 199 Pages
Global
From €3139EUR$3,545USD£2,718GBP
€3487EUR$3,939USD£3,020GBP
- Report
- July 2025
- 188 Pages
Global
From €5179EUR$5,850USD£4,486GBP
- Report
- April 2025
- 250 Pages
Global
From €3975EUR$4,490USD£3,443GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4382EUR$4,950USD£3,796GBP
- Report
- January 2022
- 60 Pages
Global
From €3497EUR$3,950USD£3,029GBP
- Report
- April 2024
- 132 Pages
Global
From €841EUR$950USD£728GBP
- Book
- August 2019
- 264 Pages
- Book
- April 2019
- 328 Pages

Peripheral Arterial Disease (PAD) is a cardiovascular condition characterized by a narrowing of the arteries that supply blood to the limbs. It is caused by a buildup of plaque in the arteries, which can lead to a decrease in blood flow and oxygen to the legs and feet. Symptoms of PAD include pain in the legs and feet, numbness, and a decrease in the ability to walk. PAD is a major cause of disability and can lead to serious complications such as stroke, heart attack, and amputation. Treatment for PAD includes lifestyle changes, medications, and surgery.
The PAD market is a subset of the larger cardiology market, which includes treatments for a variety of cardiovascular conditions. Companies in the PAD market include Abbott, Boston Scientific, Medtronic, and Johnson & Johnson. These companies offer a range of products and services, including diagnostic tests, medical devices, and pharmaceuticals. Show Less Read more